EUVIMEDEUVIMED entdecken
KommentarOpen Access

State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy

Yujie Qiao, Jiurong Liang, Dianhua Jiang

Journal of Respiratory Biology and Translational Medicine · 2025

DOI: 10.70322/jrbtm.2024.10023 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Respiratory Biology and Translational Medicine, 2025. Verfasst von Yujie Qiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Women's Guild Lung Institute, Department of Medicine, Los Angeles, CA 90048, USA. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis is a progressive pathological process that severely impairs normal organ function. Current treatments for fibrosis are extremely limited, with no curative approaches available. In a recent article published in Cell, Zhang and colleagues employed drug screening using ACTA2 reporter iPSC-derived cardiac fibroblasts and identified artesunate as a potent antifibrotic drug by targeting MD2/TLR4 signaling. This study provides new insights into strategies for exploiting existing drugs to treat fibrosis.

Schlagwörter

Stichwörter der Autor:innen

ArtesunateDrug screeningFibrosisMD2/TLR4

Autor:innen und Institutionen

  • Division of Pulmonary, Women's Guild Lung Institute, Department of Medicine, Los Angeles, CA 90048, USA.
  • Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Qiao, Y., Liang, J., & Jiang, D. (2025). State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy. Journal of Respiratory Biology and Translational Medicine. https://doi.org/10.70322/jrbtm.2024.10023

Vancouver

Qiao Y, Liang J, Jiang D. State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy. Journal of Respiratory Biology and Translational Medicine. 2025. doi:10.70322/jrbtm.2024.10023

BibTeX
@article{Qiao2025,
  author = {Qiao, Yujie and Liang, Jiurong and Jiang, Dianhua},
  title = {State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy},
  journal = {Journal of Respiratory Biology and Translational Medicine},
  year = {2025},
  doi = {10.70322/jrbtm.2024.10023}
}
Kostenlos starten →